Abdulselam Özdemir
Abdulselam Özdemir has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Güven
Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey
4 shared publications - Serhat Binici
Department of General Surgery, Faculty of Medicine, Van Yüzüncü Yıl University, 65090 Van, Türkiye
4 shared publications - Ali Rıza Karayıl
Department of General Surgery, University of Health Sciences, Van Training and Research Hospital, 65300 Van, Türkiye
3 shared publications - Serhat Uygur
Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey
3 shared publications - Adem Aslan
Department of General Surgery, Faculty of Medicine, Ağrı İbrahim Çeçen University, Ağrı 04100, Türkiye
2 shared publications - Burhan Beger
Department of Pediatric Surgery, Van Yüzüncü Yıl University Faculty of Medicine, 65080 Van, Türkiye
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3732
Computed Tomography-Derived Myosteatosis and Diaphragmatic Crus Morphology Are Associated with Radiologically Documented Recurrence Following Sliding Hiatal Hernia Repair: A Retrospective Cohort Study
Background: Systemic muscle composition and local diaphragmatic crus morphology may be associated with recurrence after sliding hiatal hernia repair. This study evaluated the associations of preoperative CT-derived muscle measurements with radiologically documented recurrence after primary type I sliding hiatal hernia repair. Methods: This retrospective single-center study identified 132 patients who underwent repair between January 2015 and July 2024. The primary recurrence analysis was restricted to 48 patients with postoperative CT. Preoperative measurements included L3 skeletal muscle attenuation and diaphragmatic crus thickness and attenuation. Associations were evaluated using between-group comparisons and separate univariable Firth penalized logistic regression models. Multivariable models and analyses involving the overall cohort were retained as exploratory supplementary analyses. Results: Among the 48 CT-imaged patients, 15 had radiologically documented recurrence and 33 had no recurrence detected on available CT. Myosteatosis was more frequent in patients with recurrence (80.0% versus 18.2%; p < 0.001). Mean crus attenuation (31.53 ± 4.69 versus 37.21 ± 3.61 HU) and thickness (5.51 ± 0.61 versus 6.39 ± 0.71 mm) were lower in patients with recurrence (both p < 0.001). In separate univariable models, myosteatosis (OR, 15.11; 95% CI, 3.84–75.00), lower crus attenuation (OR per 1-HU decrease, 1.37; 95% CI, 1.15–1.72), and reduced crus thickness (OR per 1-mm decrease, 8.02; 95% CI, 2.42–44.33) were associated with documented recurrence. These estimates were unadjusted and imprecise. Conclusions: Among selectively CT-imaged patients, myosteatosis and adverse crural muscle measurements were associated with documented recurrence. Limited events, nonstandardized imaging, and uncontrolled confounding preclude definitive prognostic conclusions. Larger studies with standardized postoperative imaging are required.
- 11 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3732
Open AccessComputed Tomography-Derived Myosteatosis and Diaphragmatic Crus Morphology Are Associated with Radiologically Documented Recurrence Following Sliding Hiatal Hernia Repair: A Retrospective Cohort Study
Background: Systemic muscle composition and local diaphragmatic crus morphology may be associated with recurrence after sliding hiatal hernia repair. This study evaluated the associations of preoperative CT-derived muscle measurements with radiologically documented recurrence after primary type I sliding hiatal hernia repair. Methods: This retrospective single-center study identified 132 patients who underwent repair between January 2015 and July 2024. The primary recurrence analysis was restricted to 48 patients with postoperative CT. Preoperative measurements included L3 skeletal muscle attenuation and diaphragmatic crus thickness and attenuation. Associations were evaluated using between-group comparisons and separate univariable Firth penalized logistic regression models. Multivariable models and analyses involving the overall cohort were retained as exploratory supplementary analyses. Results: Among the 48 CT-imaged patients, 15 had radiologically documented recurrence and 33 had no recurrence detected on available CT. Myosteatosis was more frequent in patients with recurrence (80.0% versus 18.2%; p < 0.001). Mean crus attenuation (31.53 ± 4.69 versus 37.21 ± 3.61 HU) and thickness (5.51 ± 0.61 versus 6.39 ± 0.71 mm) were lower in patients with recurrence (both p < 0.001). In separate univariable models, myosteatosis (OR, 15.11; 95% CI, 3.84–75.00), lower crus attenuation (OR per 1-HU decrease, 1.37; 95% CI, 1.15–1.72), and reduced crus thickness (OR per 1-mm decrease, 8.02; 95% CI, 2.42–44.33) were associated with documented recurrence. These estimates were unadjusted and imprecise. Conclusions: Among selectively CT-imaged patients, myosteatosis and adverse crural muscle measurements were associated with documented recurrence. Limited events, nonstandardized imaging, and uncontrolled confounding preclude definitive prognostic conclusions. Larger studies with standardized postoperative imaging are required.
- Open Access
CT-Derived Body Composition Phenotypes and Disease Severity in Acute Left-Sided Colonic Diverticulitis
Background: We evaluated associations of CT-defined sarcopenia and myosteatosis with complicated acute left-sided colonic diverticulitis (ALCD) and their incremental discrimination beyond clinical characteristics and inflammatory markers. Methods: This retrospective single-center cohort included 164 adults hospitalized with CT-confirmed ALCD. L3 skeletal muscle index (SMI) and attenuation classified patients as having neither abnormality, CT-defined sarcopenia only, myosteatosis only, or both abnormalities. Complicated ALCD was defined as World Society of Emergency Surgery (WSES) CT stage ≥ 1A. Multivariable logistic regression and bootstrap internal validation of discrimination and calibration were performed. An additional sensitivity analysis used WSES stage ≥ 1B. Results: Complicated ALCD occurred in 93/164 patients (56.7%). Proportions differed across the four phenotypes (34.7%, 48.0%, 61.5% and 78.4%; overall p < 0.001). A separate analysis showed a positive trend with the number of muscle abnormalities (0, 1 or 2; p < 0.001). After adjustment, myosteatosis alone (aOR, 4.27; 95% CI, 1.34–13.62) and both abnormalities (aOR, 9.27; 95% CI, 2.85–30.17) remained independently associated with complicated ALCD, whereas CT-defined sarcopenia alone did not. Adding muscle phenotypes to a clinical reference model containing age, sex, ASA class, ACCI, WBC and CRP increased the apparent AUC from 0.837 to 0.877 (apparent ΔAUC, 0.040; 95% CI, 0.004–0.078). Optimism-corrected AUCs were 0.812 and 0.845 (corrected ΔAUC, 0.033). The phenotype-extended clinical model had an optimism-corrected calibration slope of 0.806, indicating residual overfitting. Associations for myosteatosis and the combined phenotype were also observed using WSES stage ≥ 1B. Twelve-month CT-confirmed repeat attacks occurred in 11/121 evaluable patients (9.1%), without phenotype differences (p = 0.553). Conclusions: Myosteatosis and the combined phenotype were associated with complicated ALCD and added discriminatory information beyond the clinical reference model. Residual overfitting and the absence of external validation limit clinical application; clinical net benefit remains unestablished.
Open AccessCT-Derived Body Composition Phenotypes and Disease Severity in Acute Left-Sided Colonic Diverticulitis
Background: We evaluated associations of CT-defined sarcopenia and myosteatosis with complicated acute left-sided colonic diverticulitis (ALCD) and their incremental discrimination beyond clinical characteristics and inflammatory markers. Methods: This retrospective single-center cohort included 164 adults hospitalized with CT-confirmed ALCD. L3 skeletal muscle index (SMI) and attenuation classified patients as having neither abnormality, CT-defined sarcopenia only, myosteatosis only, or both abnormalities. Complicated ALCD was defined as World Society of Emergency Surgery (WSES) CT stage ≥ 1A. Multivariable logistic regression and bootstrap internal validation of discrimination and calibration were performed. An additional sensitivity analysis used WSES stage ≥ 1B. Results: Complicated ALCD occurred in 93/164 patients (56.7%). Proportions differed across the four phenotypes (34.7%, 48.0%, 61.5% and 78.4%; overall p < 0.001). A separate analysis showed a positive trend with the number of muscle abnormalities (0, 1 or 2; p < 0.001). After adjustment, myosteatosis alone (aOR, 4.27; 95% CI, 1.34–13.62) and both abnormalities (aOR, 9.27; 95% CI, 2.85–30.17) remained independently associated with complicated ALCD, whereas CT-defined sarcopenia alone did not. Adding muscle phenotypes to a clinical reference model containing age, sex, ASA class, ACCI, WBC and CRP increased the apparent AUC from 0.837 to 0.877 (apparent ΔAUC, 0.040; 95% CI, 0.004–0.078). Optimism-corrected AUCs were 0.812 and 0.845 (corrected ΔAUC, 0.033). The phenotype-extended clinical model had an optimism-corrected calibration slope of 0.806, indicating residual overfitting. Associations for myosteatosis and the combined phenotype were also observed using WSES stage ≥ 1B. Twelve-month CT-confirmed repeat attacks occurred in 11/121 evaluable patients (9.1%), without phenotype differences (p = 0.553). Conclusions: Myosteatosis and the combined phenotype were associated with complicated ALCD and added discriminatory information beyond the clinical reference model. Residual overfitting and the absence of external validation limit clinical application; clinical net benefit remains unestablished.
- 17 November 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-7
Linking CDH1 SNPs to gastric cancer risk: a comprehensive analysis of rs16260, rs13689, and rs9929218
Objective Single nucleotide polymorphisms (SNPs) are linked to carcinogenesis. Pathogenic variants in the CDH1 gene are associated with gastric cancer. This study examines the genotype and allele frequencies of three SNPs (rs16260, rs13689, and rs9929218) in the CDH1 gene and their relationship with gastric cancer risk. Materials and methods The study involved 105 gastric cancer patients with pathology results and 105 healthy controls. Clinical, histopathological, and demographic data were collected and compared between the two groups. Results No significant differences were found for rs16260 (− 160 C > A) and rs9929218 (G > A) between patients and controls (p > 0.05). For rs13689 (T > C), the T allele frequency was 90% in patients versus 69% in controls, while the C allele frequency was 10% in patients versus 31% in controls. A significant difference was observed for this SNP, with a higher T allele frequency in patients (OR = 4.03 CI95% 2.4–6.7, p < 0.0001) compared with controls, suggesting a fourfold increased risk of gastric cancer. Genotype frequencies were 80% wild-type (TT) and 20% heterozygous-type (TC) in patients, and 58% TT, 22% TC, and 20% mutant-type (CC) in controls (p < 0.0001). The frequencies of non-C allele carriers (TT) were present in 80% of patients versus 58.1% of controls (OR = 2.88 CI95% 1.56–5.34, p = 0.0006). Conclusion This study is the first to link the rs13689 SNP’s T allele and TT genotype with increased gastric cancer risk. Our results suggest that the rs13689 T allele may contribute significantly to disease susceptibility, while the rs16260 CC genotype and rs9929218 GG genotype may influence risk in smokers.
- 17 November 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-7
Linking CDH1 SNPs to gastric cancer risk: a comprehensive analysis of rs16260, rs13689, and rs9929218
Objective Single nucleotide polymorphisms (SNPs) are linked to carcinogenesis. Pathogenic variants in the CDH1 gene are associated with gastric cancer. This study examines the genotype and allele frequencies of three SNPs (rs16260, rs13689, and rs9929218) in the CDH1 gene and their relationship with gastric cancer risk. Materials and methods The study involved 105 gastric cancer patients with pathology results and 105 healthy controls. Clinical, histopathological, and demographic data were collected and compared between the two groups. Results No significant differences were found for rs16260 (− 160 C > A) and rs9929218 (G > A) between patients and controls (p > 0.05). For rs13689 (T > C), the T allele frequency was 90% in patients versus 69% in controls, while the C allele frequency was 10% in patients versus 31% in controls. A significant difference was observed for this SNP, with a higher T allele frequency in patients (OR = 4.03 CI95% 2.4–6.7, p < 0.0001) compared with controls, suggesting a fourfold increased risk of gastric cancer. Genotype frequencies were 80% wild-type (TT) and 20% heterozygous-type (TC) in patients, and 58% TT, 22% TC, and 20% mutant-type (CC) in controls (p < 0.0001). The frequencies of non-C allele carriers (TT) were present in 80% of patients versus 58.1% of controls (OR = 2.88 CI95% 1.56–5.34, p = 0.0006). Conclusion This study is the first to link the rs13689 SNP’s T allele and TT genotype with increased gastric cancer risk. Our results suggest that the rs13689 T allele may contribute significantly to disease susceptibility, while the rs16260 CC genotype and rs9929218 GG genotype may influence risk in smokers.
- 13 November 2024
- Published by Academician Publishing
- p. 33-42
Safra Kesesi Hastalıklarında Tanı Yöntemleri
- 13 November 2024
- Published by Academician Publishing
- p. 33-42
Safra Kesesi Hastalıklarında Tanı Yöntemleri
- Open Access
- 13 November 2024
- Published by Academician Publishing
Genel Cerrahi Bakışıyla Safra Kesesi
Tıp Tarihinde Safra Kesesi Osman Gökhan GÖKDERE Safra Kesesi Anatomisi Rifat Mert GÜLMEZ Safra Kesesi ve Safra Fizyolojisi İsa KARACA Safra Kesesi Hastalıklarına Genel Bakış Serdar ACAR Safra Kesesi Hastalıklarında Tanı Yöntemleri Abdulselam ÖZDEMİR Mustafa GÜVEN Kolelitiazis Abdül Rıdvan KULU Safra Kesesi Hastalığında Semptomlar Değercan YEŞİLYURT Safra Taşı Risk Faktörleri ve Korunma Yöntemleri M.Emin UNUTMAZ Safra Kesesi Hastalıkları ve Beslenme Ezgi TATLISU Akut Kolesistit Mustafa YENİ Akalküloz Kolesistit Ramazan Serdar ARSLAN Kronik Kolesistit Serhat BİNİCİ Mirizzi Sendromu Berke MANOĞLU Biliyer Diskinezi Yusuf Murat BAĞ Marlen SÜLEYMAN Safra Kesesi Cerrahisi Öncesinde Hastanın Preoperatif Değerlendirilmesi Ahmet KAYA Safra Kesesi Cerrahisi Öncesi Hazırlık Aziz BULUT Robotik Kolesistektomi Gökhan ULUDAĞ Saygın ALTINER Ahmet Çağrı BÜYÜKKASAP Açık Kolesistektomi Mert ADALI Hamilelikte Safra Kesesi Hastalıklarına Yaklaşım Yunus KAYCI Burak YAVUZ Yaşlılarda Safra Kesesi Hastalıklarına Yaklaşım Abdullah AS Çocuklarda Safra Kesesi Hastalıklarına Yaklaşım Murat KEĞİN Siroz ve Karaciğer Hastalıklarında Safra Kesesi Hastalıklarına Yaklaşım Halim KALE Kolesistektomi Sonrası Beslenme Ali İŞLER Postkolesistekomi Sendromu Erhan KIZILKAYA Kolesistektomi Komplikasyonları İshak AYDIN İbrahim ÇOĞAL Safra Kesesi Histolojisi & Embriyolojisi: Güncel Literatür Taraması Hayrunnisa YEŞİL SARSMAZ İatrojenik Safra Yolu Yaralanmalarına Yaklaşım Seyyit Muhsin SARIKAYA Perkütan Kolesistostomi Mustafa ORUÇ Obezite Cerrahisi ve Safra Kesesi Can AKGÜN Ahmet Can SARI Safra Kesesi Hastalıklarında Patoloji Ali Hikmet ÖZALP Zor Kolesistektomiler Burak YAVUZ Yunus KAYCI Ne Zaman Açığa Dönelim Gülay ÖZGEHAN Sils Kolesistektomi (Single İncision Laparoscopic Surgery) Mehmet UÇAR Safra Kesesi Polipleri / Porselen Kese ve Diğer Özellikli Durumlar Mustafa GÜN Mehmet Alperen AVCI
- 13 November 2024
- Published by Academician Publishing
Open AccessGenel Cerrahi Bakışıyla Safra Kesesi
Tıp Tarihinde Safra Kesesi Osman Gökhan GÖKDERE Safra Kesesi Anatomisi Rifat Mert GÜLMEZ Safra Kesesi ve Safra Fizyolojisi İsa KARACA Safra Kesesi Hastalıklarına Genel Bakış Serdar ACAR Safra Kesesi Hastalıklarında Tanı Yöntemleri Abdulselam ÖZDEMİR Mustafa GÜVEN Kolelitiazis Abdül Rıdvan KULU Safra Kesesi Hastalığında Semptomlar Değercan YEŞİLYURT Safra Taşı Risk Faktörleri ve Korunma Yöntemleri M.Emin UNUTMAZ Safra Kesesi Hastalıkları ve Beslenme Ezgi TATLISU Akut Kolesistit Mustafa YENİ Akalküloz Kolesistit Ramazan Serdar ARSLAN Kronik Kolesistit Serhat BİNİCİ Mirizzi Sendromu Berke MANOĞLU Biliyer Diskinezi Yusuf Murat BAĞ Marlen SÜLEYMAN Safra Kesesi Cerrahisi Öncesinde Hastanın Preoperatif Değerlendirilmesi Ahmet KAYA Safra Kesesi Cerrahisi Öncesi Hazırlık Aziz BULUT Robotik Kolesistektomi Gökhan ULUDAĞ Saygın ALTINER Ahmet Çağrı BÜYÜKKASAP Açık Kolesistektomi Mert ADALI Hamilelikte Safra Kesesi Hastalıklarına Yaklaşım Yunus KAYCI Burak YAVUZ Yaşlılarda Safra Kesesi Hastalıklarına Yaklaşım Abdullah AS Çocuklarda Safra Kesesi Hastalıklarına Yaklaşım Murat KEĞİN Siroz ve Karaciğer Hastalıklarında Safra Kesesi Hastalıklarına Yaklaşım Halim KALE Kolesistektomi Sonrası Beslenme Ali İŞLER Postkolesistekomi Sendromu Erhan KIZILKAYA Kolesistektomi Komplikasyonları İshak AYDIN İbrahim ÇOĞAL Safra Kesesi Histolojisi & Embriyolojisi: Güncel Literatür Taraması Hayrunnisa YEŞİL SARSMAZ İatrojenik Safra Yolu Yaralanmalarına Yaklaşım Seyyit Muhsin SARIKAYA Perkütan Kolesistostomi Mustafa ORUÇ Obezite Cerrahisi ve Safra Kesesi Can AKGÜN Ahmet Can SARI Safra Kesesi Hastalıklarında Patoloji Ali Hikmet ÖZALP Zor Kolesistektomiler Burak YAVUZ Yunus KAYCI Ne Zaman Açığa Dönelim Gülay ÖZGEHAN Sils Kolesistektomi (Single İncision Laparoscopic Surgery) Mehmet UÇAR Safra Kesesi Polipleri / Porselen Kese ve Diğer Özellikli Durumlar Mustafa GÜN Mehmet Alperen AVCI
- 28 January 2024
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 161 (5) , 381-389
Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management
Breast cancer treatment encompasses various therapeutic modalities, including surgery, radiotherapy, and chemotherapy. Breast-conserving surgery has been an integral part of breast cancer management. However, radiotherapy, an important component of breast cancer management, can lead to complications, particularly fibrosis, affecting reconstructive surgery outcomes. We conducted an in vivo study using 48 female Wistar Albino rats, employing segmental mastectomy and radiotherapy to simulate post-mastectomy conditions. The rats were divided into six groups: control, mastectomy, mastectomy + radiotherapy, mastectomy + platelet-rich plasma (PRP) + radiotherapy, mastectomy + infliximab + radiotherapy, and mastectomy + infliximab + PRP + radiotherapy. Edema, hyperemia, inflammation, and fibrosis were assessed as indicators of tissue response. Histopathological analysis revealed that mastectomy + infliximab and mastectomy + infliximab + PRP groups showed significant reductions in fibrosis compared to other groups. Edema, hyperemia, and inflammation were also less severe in these groups compared to the control group. Radiotherapy-induced fibrosis is a major concern in breast reconstruction. Our study suggests that local PRP application and systemic infliximab administration, either alone or in combination, could mitigate the adverse effects of radiotherapy. This approach has the potential to improve reconstructive outcomes in patients undergoing or having the possibility to undergo radiotherapy. This is the first study showing the effectiveness of infliximab and PRP combination on wound healing. The provided experimental rat model might offer guidance for further research. This study provides insights into optimizing outcomes in reconstructive breast surgery, paving the way for further research and clinical studies.
- 28 January 2024
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 161 (5) , 381-389
Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management
Breast cancer treatment encompasses various therapeutic modalities, including surgery, radiotherapy, and chemotherapy. Breast-conserving surgery has been an integral part of breast cancer management. However, radiotherapy, an important component of breast cancer management, can lead to complications, particularly fibrosis, affecting reconstructive surgery outcomes. We conducted an in vivo study using 48 female Wistar Albino rats, employing segmental mastectomy and radiotherapy to simulate post-mastectomy conditions. The rats were divided into six groups: control, mastectomy, mastectomy + radiotherapy, mastectomy + platelet-rich plasma (PRP) + radiotherapy, mastectomy + infliximab + radiotherapy, and mastectomy + infliximab + PRP + radiotherapy. Edema, hyperemia, inflammation, and fibrosis were assessed as indicators of tissue response. Histopathological analysis revealed that mastectomy + infliximab and mastectomy + infliximab + PRP groups showed significant reductions in fibrosis compared to other groups. Edema, hyperemia, and inflammation were also less severe in these groups compared to the control group. Radiotherapy-induced fibrosis is a major concern in breast reconstruction. Our study suggests that local PRP application and systemic infliximab administration, either alone or in combination, could mitigate the adverse effects of radiotherapy. This approach has the potential to improve reconstructive outcomes in patients undergoing or having the possibility to undergo radiotherapy. This is the first study showing the effectiveness of infliximab and PRP combination on wound healing. The provided experimental rat model might offer guidance for further research. This study provides insights into optimizing outcomes in reconstructive breast surgery, paving the way for further research and clinical studies.
- 17 October 2023
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 26 (5) , 1139-1146
Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer
Purpose Breast cancer is the most common malignancy accounting for 11.7% of all cancer cases, with a rising incidence rate. Various diagnostic methods, including 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT), play a crucial role in breast cancer diagnosis and staging. However, the unnecessary use of advanced imaging techniques such as PET/CT in early-stage breast cancer can have negative effects on both economics and patients. We aimed to investigate the impact of PET/CT on the management decisions of early-stage breast cancer patients by the breast cancer tumor board. Methods A retrospective analysis was performed on a cohort of 81 patients with early-stage breast cancer who were evaluated by breast cancer tumor board from January 2015 to December 2020. Demographic, clinical, and radiographic data, along with surgical procedures and treatment options, were documented and analyzed. Results The results showed that 18F-FDG PET/CT had a moderate impact on treatment decisions of breast cancer tumor board, as only treatment decisions were changed in 14,86% of the patients. The surgical procedure decision of breast cancer tumor board changed in 12.35% of patients, while 87.65% of patients had consistent decisions before and after PET/CT. Pathological assessments revealed invasive ductal carcinoma as the most prevalent tumor type, and molecular subtypes were predominantly luminal B. PET/CT use had limited impact on surgical procedures and did not significantly alter treatment decisions of breast cancer tumor board in this early-stage breast cancer cohort. Conclusions In conclusion, this study highlights the importance of adherence to the guidelines and appropriate use of PET/CT in early-stage breast cancer management. PET/CT should be reserved for cases where it is clinically warranted, considering the potential economic burden and minimal impact on treatment decisions of breast cancer tumor board in this patient population.
- 17 October 2023
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 26 (5) , 1139-1146
Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer
Purpose Breast cancer is the most common malignancy accounting for 11.7% of all cancer cases, with a rising incidence rate. Various diagnostic methods, including 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT), play a crucial role in breast cancer diagnosis and staging. However, the unnecessary use of advanced imaging techniques such as PET/CT in early-stage breast cancer can have negative effects on both economics and patients. We aimed to investigate the impact of PET/CT on the management decisions of early-stage breast cancer patients by the breast cancer tumor board. Methods A retrospective analysis was performed on a cohort of 81 patients with early-stage breast cancer who were evaluated by breast cancer tumor board from January 2015 to December 2020. Demographic, clinical, and radiographic data, along with surgical procedures and treatment options, were documented and analyzed. Results The results showed that 18F-FDG PET/CT had a moderate impact on treatment decisions of breast cancer tumor board, as only treatment decisions were changed in 14,86% of the patients. The surgical procedure decision of breast cancer tumor board changed in 12.35% of patients, while 87.65% of patients had consistent decisions before and after PET/CT. Pathological assessments revealed invasive ductal carcinoma as the most prevalent tumor type, and molecular subtypes were predominantly luminal B. PET/CT use had limited impact on surgical procedures and did not significantly alter treatment decisions of breast cancer tumor board in this early-stage breast cancer cohort. Conclusions In conclusion, this study highlights the importance of adherence to the guidelines and appropriate use of PET/CT in early-stage breast cancer management. PET/CT should be reserved for cases where it is clinically warranted, considering the potential economic burden and minimal impact on treatment decisions of breast cancer tumor board in this patient population.
- Open Access
- 1 August 2023
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 9 (2) , 72-77
Infections that may be missed during the COVID-19 pandemic, legionella pneumophila infection: A case report
During pandemics, certain uncommon diseases might manifest within vulnerable populations. An example is Legionella spp, an aerobic, gram-negative pathogen that can thrive intracellularly. This microorganism holds significance for public health, being responsible for both pneumonia acquired in community settings and healthcare settings. Among Legionella cases, Legionella pneumophila accounts for about 90% of them. When observing coronavirus disease 2019 (COVID-19) patients in the intensive care unit, it's crucial to consider Legionella as a possible alternative diagnosis due to its similar clinical manifestations. In this case report, we aim to highlight a 43-year-old male patient, previously without any chronic conditions, who was initially diagnosed with COVID-19 but later identified to have Legionella pneumonia , presenting with symptoms including confusion, dysarthria, weakness, pain, and respiratory failure upon hospital admission.
- 1 August 2023
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 9 (2) , 72-77
Open AccessInfections that may be missed during the COVID-19 pandemic, legionella pneumophila infection: A case report
During pandemics, certain uncommon diseases might manifest within vulnerable populations. An example is Legionella spp, an aerobic, gram-negative pathogen that can thrive intracellularly. This microorganism holds significance for public health, being responsible for both pneumonia acquired in community settings and healthcare settings. Among Legionella cases, Legionella pneumophila accounts for about 90% of them. When observing coronavirus disease 2019 (COVID-19) patients in the intensive care unit, it's crucial to consider Legionella as a possible alternative diagnosis due to its similar clinical manifestations. In this case report, we aim to highlight a 43-year-old male patient, previously without any chronic conditions, who was initially diagnosed with COVID-19 but later identified to have Legionella pneumonia , presenting with symptoms including confusion, dysarthria, weakness, pain, and respiratory failure upon hospital admission.
- 14 September 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 31 (3) , 217-223
The Relationship Between Smartphone Use in the Lavatory and Hemorrhoidal Disease
- 14 September 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 31 (3) , 217-223
The Relationship Between Smartphone Use in the Lavatory and Hemorrhoidal Disease
- 1 January 2021
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 17 (1) , 15-20
Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors
Objective: The prognosis of breast cancer (BC) is determined directly based on the stage of disease at the time of diagnosis. Proliferative breast lesions (PBLs) are an important risk factor for BC development. The risk of developing BC varies according to the presence of extent of proliferation in the breast lesions. We aimed to investigate the effect of BC risk factors on the PBLs in this study. Materials and Methods: Patients who visited the surgical clinic of the university during the past 6 years who presented with PBLs with or without atypia by fine/core needle aspiration biopsy were included in this study. The relationship between PBLs and BC risk factors such as the age, mass size, Body Mass index (BMI), smoking, sports activity, BC family history, the use of hormone replacement therapy, number of pregnancies, and the duration of breastfeeding were compared. Results: A total of 74 (96.1%) of all patients were women and three were men. The median age of the patients was 38 (range: 19-74) years; the cut-off value of age was 35.5 years. The mean age of patients with PBL-with atypia (PBL-WA) was higher (p=0.005) in the malignant group based on the final pathology and radiological imaging features (for both, p<0.001). The mean size of the mass was large at 2.53 +/- 1.33 (1-6) cm; and the cut-off value of the tumor size was 2.5 cm. The mean size was greater in the PBL-WA patients (p=0.171) in the malignant group based on the final pathology and radiological characteristic (respectively, p=0.004 and p=0.016). The mean BMI was 26.8 +/- 4.4 kg/m(2) (18.8-35.1) and the cut-off value was 25.4 kg/m(2). BMI was greater in the PBL-WA group and in the malignant group based on the final pathology (respectively, p=0.002 and p=0.001). Smoking was positive in 66.2% (n=51) of the patients, and it was high in the PBL-WA patients (p=0.001). The percentage of patients with no sports activity was 63.6% (n=49), while it was 20.8% (n=16) for those with once a week sports activity and 15.6% (n=12) for those with twice a week activity. There was family history of BC in 16.9% (n=13) of all patients. The number of positive cases of family history of BC was greater in the malignant group (p=0.001). Hormone replacement therapy was recorded in 11.7% (n=9) of the patients. The mean numbers of pregnancies (2.1 +/- 2.4) and breastfeeding duration (32.5 +/- 37.4 months) were low in the benign groups due to the relatively lower average age of the patients. Conclusion: Based on our analysis, age is an extremely important aspect for assessing PBLs. The age of the patient was statistically significantly greater in the patients with malignant lesions in all groups. The factors lesion size, BMI, smoking habit, and BC family history were also more frequent in the malignant groups. The rate of sports activity was lower in the malignant groups. Thus, it is necessary to evaluate patients individually when evaluating PBLs. It is recommended to evaluate PBLs together with BC risk factors for the better understanding.
- 1 January 2021
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 17 (1) , 15-20
Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors
Objective: The prognosis of breast cancer (BC) is determined directly based on the stage of disease at the time of diagnosis. Proliferative breast lesions (PBLs) are an important risk factor for BC development. The risk of developing BC varies according to the presence of extent of proliferation in the breast lesions. We aimed to investigate the effect of BC risk factors on the PBLs in this study. Materials and Methods: Patients who visited the surgical clinic of the university during the past 6 years who presented with PBLs with or without atypia by fine/core needle aspiration biopsy were included in this study. The relationship between PBLs and BC risk factors such as the age, mass size, Body Mass index (BMI), smoking, sports activity, BC family history, the use of hormone replacement therapy, number of pregnancies, and the duration of breastfeeding were compared. Results: A total of 74 (96.1%) of all patients were women and three were men. The median age of the patients was 38 (range: 19-74) years; the cut-off value of age was 35.5 years. The mean age of patients with PBL-with atypia (PBL-WA) was higher (p=0.005) in the malignant group based on the final pathology and radiological imaging features (for both, p<0.001). The mean size of the mass was large at 2.53 +/- 1.33 (1-6) cm; and the cut-off value of the tumor size was 2.5 cm. The mean size was greater in the PBL-WA patients (p=0.171) in the malignant group based on the final pathology and radiological characteristic (respectively, p=0.004 and p=0.016). The mean BMI was 26.8 +/- 4.4 kg/m(2) (18.8-35.1) and the cut-off value was 25.4 kg/m(2). BMI was greater in the PBL-WA group and in the malignant group based on the final pathology (respectively, p=0.002 and p=0.001). Smoking was positive in 66.2% (n=51) of the patients, and it was high in the PBL-WA patients (p=0.001). The percentage of patients with no sports activity was 63.6% (n=49), while it was 20.8% (n=16) for those with once a week sports activity and 15.6% (n=12) for those with twice a week activity. There was family history of BC in 16.9% (n=13) of all patients. The number of positive cases of family history of BC was greater in the malignant group (p=0.001). Hormone replacement therapy was recorded in 11.7% (n=9) of the patients. The mean numbers of pregnancies (2.1 +/- 2.4) and breastfeeding duration (32.5 +/- 37.4 months) were low in the benign groups due to the relatively lower average age of the patients. Conclusion: Based on our analysis, age is an extremely important aspect for assessing PBLs. The age of the patient was statistically significantly greater in the patients with malignant lesions in all groups. The factors lesion size, BMI, smoking habit, and BC family history were also more frequent in the malignant groups. The rate of sports activity was lower in the malignant groups. Thus, it is necessary to evaluate patients individually when evaluating PBLs. It is recommended to evaluate PBLs together with BC risk factors for the better understanding.